3824 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 77 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
AAASAladin WD repeat nucleoporinDisease related genes
Potential drug targets
Predicted intracellular proteins
Transporters
Nuclear membrane
Centrosome
Cytosol
Renal cancer: 2.93e-4
Expressed in all
AAGABAlpha- and gamma-adaptin binding proteinDisease related genes
Predicted intracellular proteins
Nuclear speckles
Cytosol
Renal cancer: 1.36e-4
Thyroid cancer: 9.48e-4
Expressed in all
AARSAlanyl-tRNA synthetaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
CytosolExpressed in all
AARS2Alanyl-tRNA synthetase 2, mitochondrialCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
MitochondriaMixed
AASSAminoadipate-semialdehyde synthaseDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Vesicles
Mitochondria
Liver cancer: 9.81e-4
Mixed
ABAT4-aminobutyrate aminotransferaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
MitochondriaRenal cancer: 5.44e-8
Liver cancer: 5.36e-5
Lung cancer: 5.93e-4
Tissue enhanced
ABCA1ATP binding cassette subfamily A member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Vesicles
Mixed
ABCA12ATP binding cassette subfamily A member 12Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoli
Vesicles
Plasma membrane
Cytosol
Group enriched
ABCA3ATP binding cassette subfamily A member 3Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Cytosol
Tissue enhanced
ABCA4ATP binding cassette subfamily A member 4Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Lung cancer: 2.45e-4
Urothelial cancer: 2.72e-4
Tissue enhanced
ABCA7ATP binding cassette subfamily A member 7Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Golgi apparatus
Plasma membrane
Cell Junctions
Endometrial cancer: 1.12e-4
Colorectal cancer: 7.26e-4
Mixed
ABCB1ATP binding cassette subfamily B member 1Cancer-related genes
CD markers
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Focal adhesion sites
Cytosol
Renal cancer: 2.95e-4
Pancreatic cancer: 3.33e-4
Tissue enhanced
ABCB11ATP binding cassette subfamily B member 11Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Plasma membrane
Cytosol
Tissue enriched
ABCB4ATP binding cassette subfamily B member 4Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Plasma membrane
Actin filaments
Focal adhesion sites
Tissue enriched
ABCB6ATP binding cassette subfamily B member 6 (Langereis blood group)Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Golgi apparatus
Plasma membrane
Mitochondria
Cytosol
Renal cancer: 1.52e-7
Liver cancer: 9.45e-7
Expressed in all
ABCB7ATP binding cassette subfamily B member 7Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
MitochondriaRenal cancer: 5.31e-6
Expressed in all
ABCC2ATP binding cassette subfamily C member 2Cancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Renal cancer: 1.93e-5
Group enriched
ABCC6ATP binding cassette subfamily C member 6Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Plasma membraneLiver cancer: 3.82e-4
Tissue enhanced
ABCC8ATP binding cassette subfamily C member 8Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Nucleoli
Golgi apparatus
Cytosol
Tissue enhanced
ABCC9ATP binding cassette subfamily C member 9Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Cytosol
Renal cancer: 1.85e-5
Mixed
ABCD1ATP binding cassette subfamily D member 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Renal cancer: 5.50e-4
Expressed in all
ABCD3ATP binding cassette subfamily D member 3Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
PeroxisomesColorectal cancer: 1.16e-5
Renal cancer: 4.84e-5
Expressed in all
ABCD4ATP binding cassette subfamily D member 4Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
ABCG5ATP binding cassette subfamily G member 5Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
NucleusLiver cancer: 2.60e-5
Group enriched
ABCG8ATP binding cassette subfamily G member 8Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
VesiclesGroup enriched
ABHD11Abhydrolase domain containing 11Disease related genes
Predicted intracellular proteins
MitochondriaRenal cancer: 3.66e-7
Expressed in all
ABHD12Abhydrolase domain containing 12Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Cervical cancer: 1.30e-5
Breast cancer: 3.81e-5
Liver cancer: 7.18e-4
Expressed in all
ABHD5Abhydrolase domain containing 5Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
VesiclesRenal cancer: 9.17e-5
Colorectal cancer: 8.89e-4
Expressed in all
ABI1Abl interactor 1Cancer-related genes
Disease related genes
Predicted intracellular proteins
Plasma membrane
Cell Junctions
Expressed in all
ABL1ABL proto-oncogene 1, non-receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Nucleoplasm
Nuclear bodies
Expressed in all
ACACAAcetyl-CoA carboxylase alphaDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Nucleoli fibrillar center
Actin filaments
Cytosol
Liver cancer: 1.24e-5
Mixed
ACAD8Acyl-CoA dehydrogenase family member 8Disease related genes
Predicted intracellular proteins
Renal cancer: 6.42e-10
Lung cancer: 2.38e-4
Head and neck cancer: 6.19e-4
Colorectal cancer: 7.62e-4
Expressed in all
ACAD9Acyl-CoA dehydrogenase family member 9Disease related genes
Predicted intracellular proteins
MitochondriaRenal cancer: 4.32e-8
Liver cancer: 3.67e-6
Endometrial cancer: 3.05e-4
Expressed in all
ACADLAcyl-CoA dehydrogenase, long chainDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Renal cancer: 1.58e-11
Tissue enhanced
ACADMAcyl-CoA dehydrogenase, C-4 to C-12 straight chainDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
MitochondriaRenal cancer: 3.83e-8
Colorectal cancer: 7.30e-4
Expressed in all
ACADSAcyl-CoA dehydrogenase, C-2 to C-3 short chainDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
MitochondriaRenal cancer: 3.33e-6
Urothelial cancer: 6.34e-5
Liver cancer: 2.43e-4
Endometrial cancer: 5.05e-4
Glioma: 9.94e-4
Expressed in all
ACADSBAcyl-CoA dehydrogenase, short/branched chainDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
MitochondriaRenal cancer: 6.37e-12
Pancreatic cancer: 3.40e-4
Expressed in all
ACADVLAcyl-CoA dehydrogenase, very long chainDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Nucleus
Nucleoli
Mitochondria
Pancreatic cancer: 6.87e-4
Expressed in all
ACAT1Acetyl-CoA acetyltransferase 1Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
MitochondriaRenal cancer: 0.00e+0
Liver cancer: 1.43e-5
Expressed in all
ACDACD, shelterin complex subunit and telomerase recruitment factorDisease related genes
Predicted intracellular proteins
Nuclear bodiesLiver cancer: 2.42e-6
Mixed
ACEAngiotensin I converting enzymeCandidate cardiovascular disease genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesTissue enhanced
ACO2Aconitase 2Citric acid cycle related proteins
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
MitochondriaRenal cancer: 0.00e+0
Expressed in all
ACOX1Acyl-CoA oxidase 1Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Nucleus
Vesicles
Renal cancer: 5.25e-7
Expressed in all
ACP2Acid phosphatase 2, lysosomalDisease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Endometrial cancer: 1.04e-4
Expressed in all
ACP5Acid phosphatase 5, tartrate resistantDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
CytosolTissue enhanced
ACPTAcid phosphatase, testicularDisease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Tissue enhanced
ACSF3Acyl-CoA synthetase family member 3Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Renal cancer: 5.97e-6
Pancreatic cancer: 3.76e-5
Expressed in all
ACSL4Acyl-CoA synthetase long-chain family member 4Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Golgi apparatus
Mitochondria
Urothelial cancer: 5.73e-4
Expressed in all
ACSL6Acyl-CoA synthetase long-chain family member 6Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
ACTA1Actin, alpha 1, skeletal muscleDisease related genes
Plasma proteins
Predicted intracellular proteins
Tissue enriched
Page of 77 | next »